BCM Department of Medicine
Previous Home Home Next

Thrombosis Research Section Faculty

 

Faculty (Secondary Appointment)

JAMES E. MUNTZ, M.D.

 

 

 

Research Interests:

James E. Muntz is Clinical Associate Professor of Medicine and Clinical Associate Professor of Orthopedic Surgery at Baylor College of Medicine, and Clinical Associate Professor of Internal Medicine at the University of Texas Health Science Center. After graduating Phi Beta Kappa from Indiana University, Dr Muntz received his medical degree from Baylor College of Medicine and his postgraduate education at St Luke's Episcopal Hospital and Baylor College of Medicine Affiliated Hospitals. Dr. Muntz' area of research interest is thromboprophylaxis for venous thromboembolism, with a special focus on the management of orthopedic surgery patients. He has participated in numerous clinical trials of novel anticoagulants and new anticoagulant regimens, and has presented his findings at more than 400 conferences and has been interviewed by the television networks ABC, NBC, ESPN and CNN. In 1995, Dr Muntz received the Outstanding Internist award presented by the Department of Orthopedic Surgery at Baylor College of Medicine. He currently serves on the Advisory Board of the American Heart Association. He is also team physician for the NBA Houston Rockets, the Houston Astros major league baseball team, and the NFL Houston Texans.

 

Selected Publications:

1. Risks of venous thrombosis in non-large joint surgery. Am J Orthop Surg. Pending publication.

2. M. Kwong and JE Muntz. Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy and safety. Am J Orthop Surg. 2002;31(11S):16-20.

3. JE Muntz. Optimizing antithrombotic therapy for venous thromboembolism prophylaxis. Am J Orthop. 2002;31(4S).

4. JE Muntz, AG Turpie, K Bauer, et al. The first synthetic factor anti XA inhibitor, pentasaccharide (arixtra) compared with low molecular weight heparin to prevent venous thromboembolism. J South Orthop Assoc 2001;10(2):119-120.

5. Highlights Newsletter, March 2001. New Therapies: Selective Clotting Factor Inhibition. Authors: John McCuthen, MD; James Muntz, MD; Louis M. Kwong, MD; Michael R. Lassen, MD. From venous thromboembolic Disease After Orthopedic Surgery: Breakthroughs in Prophylaxis from December 15, 2000.

6. JE Muntz. Advances in thrombosis/Hemostasis. World-Wide Medical Information Service, Scientia Magazine 2001;4(4).

7. JE Muntz, Guest Editor. Issue on Atherosclerosis and Thrombosis. Scientia Magazine; February 2001.

8. JE Muntz. Risk assessment anticoagulation general surgery patient: venous thromboembolism - bridging therapy with anticoagulation. Surg Rounds 2000: 9-11.

9. JE Muntz. Deep vein thrombosis and pulmonary embolism in the perioperative patient. Am J Manag Care November 2000.


10. Presentation: JE Muntz. Advances in the Prevention and Treatment of Thrombotic Complications in the Rehabilitation Patient, Wednesday November 10, 1999, Washington D.C.


Previous Home Home Next
BCM Home Page©1995-2003 Baylor College of Medicine

Email: medicine@bcm.tmc.edu
URL: http://public.bcm.tmc.edu/medicine/muntz.htm (Modified: June 4, 2003)